Chennai, January 2025
This National Girl Child Day, Dr. D. Srinivasan, a renowned paediatrician in Chennai, has taken a monumental step by vaccinating girl children from underprivileged backgrounds against chickenpox disease in Ashok Nagari. Varicella virus causes chickenpox, a highly contagious disease that results in an itchy rash of blisters and, in most cases, leaves permanent scars on the patient. 1 in 3 patients tend to develop herpes at a later stage, which is one of the most painful diseases. The Varicella virus can cause serious complications during pregnancy and, in most cases, fatal for the mother and the newborn baby. It can lead to maternal mortality, fetal varicella syndrome and neonatal varicella. The vaccine to prevent chickenpox is not included in the National Immunization Programme (NIP), which means that more than 90% of children in India go unvaccinated. This initiative highlights the importance of equitable healthcare access for girls and promotes awareness about the critical need for vaccination, especially from unprivileged communities.
India faces alarming disparities in vaccination coverage. According to UNICEF, female children living in slums or rural areas often face greater barriers to receiving vaccinations due to societal and financial constraints. Families with limited resources often prioritise boys over girls, further exacerbating this inequity. Studies also show that maternal literacy is crucial in determining daughter vaccination rates.
“Every girl, irrespective of any social status, have the right to receiving basic healthcare, including vaccinations. On this National Girl Child Day, our goal was to change that narrative by providing them with a vaccine that not only protects against chickenpox but also sets a benchmark in efficacy and safety. Every girl child deserves the opportunity to grow up healthy and strong,” said Dr. D. Srinivasan.
The chickenpox vaccine used during this drive represents a significant advancement in healthcare. Its formulation ensures the highest level of protection, with negligible breakthrough infections after vaccination. It is the only chickenpox vaccine in the world that remains effective without losing its potency even if the cold chain breaks, for up to 28 days and has the highest shelf life of 36 months. This ensures that even the most vulnerable populations can benefit from its efficacy. Additionally, the absence of Gelatin in its composition reduces the risk of allergic reactions, making it the safest choice for children.
This initiative provides immediate health benefits and serves as a call to action for addressing the systemic barriers female children face in accessing essential healthcare services, preparing them for better adulthood while safeguarding their future.
Dr. Neminathan K, Coimbatore said, “This initiative is a small step toward addressing the systemic inequities in healthcare for girl children. Chickenpox can lead to serious complications, especially in children with limited access to timely medical care. By vaccinating them effectively, we’re ensuring these girls have the best defense against this preventable disease and a healthier start in life”.
